John Y. Pickstone (ed.), Medical innovations in historical perspective. Basingstoke and London, Macmillan (in association with the Centre for the History of Science, Technology and Medicine, University of Manchester), 1992. XV, 288 S. (Science, Technology and Medicine in Modern History). £40.-. ISBN 0-333-55619-4. [PDF]
, 1993 Antoinette Stettier
openalex +1 more source
Information Technology and Medical Missteps: Evidence from a Randomized Trial [PDF]
We analyze the effect of a decision support tool designed to help physicians detect and correct medical "missteps". The data comes from a randomized trial of the technology on a population of commercial HMO patients.
James B. Rebitzer +2 more
core
Molecular Oncology, EarlyView.Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi +12 more
wiley +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
Molecular Oncology, EarlyView.In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza +3 more
wiley +1 more source
Evolution in medical technology education
, 1969 Brad Love, Rory Conn, C K Sleeth
openalex +1 more source
Banks building markets by building communities [PDF]
Banks, their customers and the local community share the long-term benefits of meaningful community investments.Community development ; Community banks ; Education - Economic aspects ; Technology - Economic aspects ; Medical ...
Community Affairs Office
core
Molecular Oncology, EarlyView.Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source
Medical Technology: A Systematic Review on Medical Devices Utilized for Epilepsy Prediction and Management. [PDF]
Curr Neuropharmacol, 2022 Ong JS +4 more
europepmc +1 more source
Tailored Patient Information: Some Issues and Questions
, 1997 Tailored patient information (TPI) systems are computer programs which produce personalised heath-information material for patients. TPI systems are of growing interest to the natural-language generation (NLG) community; many TPI systems have also been ...
Osman, Liesl, Reiter, Ehud
core +3 more sources